Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    "familial hypobetalipoproteinemia" OR "Hypobetalipoproteinemias"
Show Display Options
RSS Create an RSS feed from your search for:
"familial hypobetalipoproteinemia" OR "Hypobetalipoproteinemias"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention
Condition: Hypobetalipoproteinemias
Interventions: Drug: Tocofersolan;   Drug: tocopherol alpha;   Drug: Tocofersolan and tocopherol alpha
2 Completed Mechanisms of Low Levels of Apolipoprotein B
Conditions: Cardiovascular Diseases;   Heart Diseases;   Hypobetalipoproteinemia
Intervention:
3 Not yet recruiting HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
Condition: Hypobetalipoproteinemia
Intervention: Genetic: hypobetalipoproteinemia genetic and genotypic screening
4 Completed Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
Conditions: Lipid Metabolism, Inborn Errors;   Hyperlipidemias;   Metabolic Diseases;   Hypolipoproteinemia;   Hypolipoproteinemias;   Hypobetalipoproteinemias;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Congenital Abnormalities;   Metabolic Disorder;   Hypercholesterolemia;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: ISIS 301012 (mipomersen)  sodium;   Drug: Placebo;   Drug: ISIS 301012 (mipomersen) sodium;   Drug: placebo;   Drug: ISIS 301012 (mipomersen)   sodium
5 Completed Vitamin Replacement in Abetalipoproteinemia
Condition: Abetalipoproteinemia
Intervention:
6 Recruiting Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Conditions: Abetalipoproteinemia;   Atherosclerosis;   Healthy;   Inborn Errors Lipid Metabolism
Intervention:

Indicates status has not been verified in more than two years